Daxor EBITDA 2010-2011 | DXR
Daxor ebitda from 2010 to 2011. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Daxor Annual EBITDA (Millions of US $) |
|
|---|---|
| 2011 | $-5 |
| 2010 | $-5 |
| 2009 | $-5 |
| Daxor Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-1 |
| 2011-03-31 | $-2 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $-1 |
| 2010-06-30 | $-1 |
| 2010-03-31 | $-1 |
| 2009-12-31 | $-1 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.052B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $20.168B | 19.27 |
| Encompass Health (EHC) | United States | $12.282B | 24.53 |
| DaVita (DVA) | United States | $9.916B | 14.18 |
| Elanco Animal Health (ELAN) | United States | $8.893B | 19.89 |
| Chemed (CHE) | United States | $6.503B | 21.78 |
| RadNet (RDNT) | United States | $5.428B | 196.03 |
| Option Care Health (OPCH) | United States | $4.531B | 19.39 |
| Addus HomeCare (ADUS) | United States | $2.101B | 22.65 |
| LifeStance Health (LFST) | United States | $2.100B | 0.00 |
| Astrana Health (ASTH) | United States | $1.698B | 59.39 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.602B | 29.50 |
| U.S Physical Therapy (USPH) | United States | $1.277B | 31.95 |
| Atai Life Sciences (ATAI) | Germany | $1.035B | 0.00 |
| Pennant (PNTG) | United States | $0.839B | 29.60 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.054B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |